Five-year Results of the PERLE Implant in Breast Augmentation and Augmentation-mastopexy.

IF 3 2区医学 Q1 SURGERY

Aesthetic Surgery Journal Pub Date : 2026-04-15 DOI:10.1093/asj/sjag074

James Lucocq, Taimur Shoaib

{"title":"Five-year Results of the PERLE Implant in Breast Augmentation and Augmentation-mastopexy.","authors":"James Lucocq, Taimur Shoaib","doi":"10.1093/asj/sjag074","DOIUrl":null,"url":null,"abstract":"Background: Advances in the manufacturing of breast implants through improved shell architecture, gel cohesivity, and surface topography may mitigate against post-operative complications following breast augmentation.Objectives: The present study aims to report five-year results of the PERLE implant (GC Aesthetics) which is a round breast implant with an average surface roughness of 5 μm that was launched in 2020.Methods: A retrospective cohort study was performed including consecutive patients undergoing primary or secondary bilateral breast augmentation and augmentation-mastopexy with PERLE implants between December 2020-2025. The primary outcomes were implant-related complications and re-operation over five years. Outcomes were analysed per-patient and per-implant.Results: 738 patients (augmentation, n=592; augmentation-mastopexy, n=146) receiving 1,476 implants were followed up for up to five years (median follow-up, 34 months). Implant-related complications occurred in 2.8% of patients overall: 2.2% (13/592) following augmentation and 5.5% (8/146) following augmentation-mastopexy. The per-patient rate of capsular contracture was 0.5% following augmentation (n=3) and 0.7% following augmentation-mastopexy (n=1). Per-implant, the overall rate of capsular contracture was 0.3% (subglandular, 0.4% [2/476]; dual-plane, 0.3% [2/690]; subfascial, 0.0% [0/296]; and submuscular, 0.0% [0/14]). The rate of implant malposition was 0.7% and 1.4% per implant inserted, following augmentation and augmentation-mastopexy, respectively. The 1-, 3- and 5-year re-operation rate for implant-related complications was 1.2%, 2.1% and 2.5%, respectively in the augmentation group. No cases of implant rupture, rippling or BIA-ALCL were reported.Conclusions: At five years, breast augmentation and augmentation-mastopexy using the PERLE implant demonstrated low rates of capsular contracture, implant malposition, and implant-related re-operation.","PeriodicalId":7728,"journal":{"name":"Aesthetic Surgery Journal","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aesthetic Surgery Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/asj/sjag074","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Advances in the manufacturing of breast implants through improved shell architecture, gel cohesivity, and surface topography may mitigate against post-operative complications following breast augmentation.

Objectives: The present study aims to report five-year results of the PERLE implant (GC Aesthetics) which is a round breast implant with an average surface roughness of 5 μm that was launched in 2020.

Methods: A retrospective cohort study was performed including consecutive patients undergoing primary or secondary bilateral breast augmentation and augmentation-mastopexy with PERLE implants between December 2020-2025. The primary outcomes were implant-related complications and re-operation over five years. Outcomes were analysed per-patient and per-implant.

Results: 738 patients (augmentation, n=592; augmentation-mastopexy, n=146) receiving 1,476 implants were followed up for up to five years (median follow-up, 34 months). Implant-related complications occurred in 2.8% of patients overall: 2.2% (13/592) following augmentation and 5.5% (8/146) following augmentation-mastopexy. The per-patient rate of capsular contracture was 0.5% following augmentation (n=3) and 0.7% following augmentation-mastopexy (n=1). Per-implant, the overall rate of capsular contracture was 0.3% (subglandular, 0.4% [2/476]; dual-plane, 0.3% [2/690]; subfascial, 0.0% [0/296]; and submuscular, 0.0% [0/14]). The rate of implant malposition was 0.7% and 1.4% per implant inserted, following augmentation and augmentation-mastopexy, respectively. The 1-, 3- and 5-year re-operation rate for implant-related complications was 1.2%, 2.1% and 2.5%, respectively in the augmentation group. No cases of implant rupture, rippling or BIA-ALCL were reported.

Conclusions: At five years, breast augmentation and augmentation-mastopexy using the PERLE implant demonstrated low rates of capsular contracture, implant malposition, and implant-related re-operation.

查看原文本刊更多论文

PERLE假体在隆胸和隆胸-乳房切除术中的五年效果。

背景：乳房植入物制造技术的进步，通过改进外壳结构、凝胶黏结性和表面形貌，可以减轻隆胸术后并发症。目的：本研究旨在报告PERLE假体（GC Aesthetics）的五年成果，PERLE假体是一种圆形乳房假体，平均表面粗糙度为5 μm，于2020年推出。方法：回顾性队列研究包括在2020年12月至2025年12月期间接受原发性或继发性双侧隆胸和PERLE假体隆胸-乳房切除术的连续患者。主要结果是种植体相关并发症和5年内再次手术。对每个患者和每个种植体的结果进行分析。结果：738例患者（隆胸，n=592；隆胸-乳房固定术，n=146）接受了1476个种植体，随访时间长达5年（中位随访时间为34个月）。种植体相关并发症发生率为2.8%：隆胸后为2.2%(13/592)，隆胸-乳房固定术后为5.5%（8/146）。每位患者包膜挛缩率在隆胸后为0.5% (n=3)，在隆胸-乳房固定术后为0.7% （n=1）。种植体的囊膜挛缩率为0.3%（腺下，0.4%[2/476]；双平面，0.3%[2/690]；筋膜下，0.0%[0/296]；肌下，0.0%[0/14]）。隆胸和隆胸-乳房固定术后种植体错位率分别为0.7%和1.4%。增强组1年、3年和5年再手术与种植体相关的并发症发生率分别为1.2%、2.1%和2.5%。无种植体破裂、波纹或BIA-ALCL病例报道。结论：使用PERLE假体进行隆胸和隆乳术的患者在术后5年内出现囊膜挛缩、假体错位和假体相关再手术的几率较低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Aesthetic Surgery Journal SURGERY-

CiteScore

6.20

自引率

20.70%

发文量

309

审稿时长

6-12 weeks

期刊介绍： Aesthetic Surgery Journal is a peer-reviewed international journal focusing on scientific developments and clinical techniques in aesthetic surgery. The official publication of The Aesthetic Society, ASJ is also the official English-language journal of many major international societies of plastic, aesthetic and reconstructive surgery representing South America, Central America, Europe, Asia, and the Middle East. It is also the official journal of the British Association of Aesthetic Plastic Surgeons, the Canadian Society for Aesthetic Plastic Surgery and The Rhinoplasty Society.